ncRNA name
CircSAMD4A
Specific or universal ncRNAs
Specific ncRNAs
Class
Circular RNA
Biomarker
None
Biomarker application
Upstream regulatory factors
Not available
Downstream target
miR-218-5p/KLF8
Cancer name
Osteosarcoma
Cancer site
qRT-PCR,Western blot,Dual-luciferase assay
Treatment type
Chemotherapy
Drug
Doxorubicin
Impact of wild-type ncRNA on chemotherapy resistance
Up
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Up
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
CircSAMD4A contributes to cell doxorubicin resistance in osteosarcoma by regulating the miR-218-5p/KLF8 axis
Tissue resource
tumor tissues and para-carcinoma tissues from osteosarcoma patients
human osteosarcoma cell lines HOS
human osteosarcoma cell lines U2OS
human osteoblast cell line hFOB1.19
Experiment
None
Institute
Shaoxing Shangyu People's Hospital
Shanghai Academy of Life Science
Country
China
China
Continent
Asia
Asia